Pharma: Key Legal and Business Issues|
Date(s): 12.02.09 | Wednesday
Time: 5:00 p.m. - 8:15 p.m.
Location: McNally Amphitheatre and Platt Atrium
Sponsor: Intellectual Property Law Institute and Corporate Law Center
Speaker: Panel Discussion
The Intellectual Property Law Institute and the Corporate Law Center will host an expert panel entitled Pharma: Key Legal and Business Issues, on Wednesday, December 2, 2009 at Fordham Law School.
5:00 p.m. Meet the speakers at a reception in the Platt Atrium.
5:45 p.m. Introduction
6:00 p.m. Legal Issues Panel
7:00 p.m. Business Issues Panel
Both the program and reception are complimentary.
Everyone is welcome to attend. Registration is encouraged, but not required.
Registration at: email@example.com
For further information: firstname.lastname@example.org or email@example.com
Business strategy in the pharmaceutical industry is subject to numerous constraints, not least of which are the legal and scientific exigencies associated with patenting new drugs (and "evergreening" existing drugs). The proposed panel will address these constraints, and explore how concerns relating to patents influence near-and long-term business strategies. What is the effect of proposed Hatch-Waxman legislation on continued development and marketing of biologics? What is the economic impact of generic manufacturers' "launch at risk" strategies? How are patent litigation settlements affecting long-term business decisions in the industry? How does the declining number of patents affect the long-term viability of generic manufacturers? Legal and business experts from across the pharmaceutical industry will discuss these issues.
Legal Issues Panel (6:00 p.m.)
Moderator: Hugh Hansen, Professor, Fordham Law School
Director, Fordham Intellectual Property Law Institute
Nicholas Groombridge (Weil, Gotshal & Manges LLP)
John LaRocca (General Counsel, Actavis)
Steven J. Lee, Ph.D. (Kenyon & Kenyon LLP)
David Manspeizer (Former Chief Patent Counsel, Wyeth)
John Richards (Ladas & Parry LLP)
Business Issues Panel (7:00 p.m.)
Moderator: Howard Tuckman, Ph.D. Professor of Finance and Economics
Fordham Graduate School of Business
Ken Banta (Chairman & CEO, The Transatlantic Group and Advisor to Merck on Corporate Affairs)
Edwin A. Cohen (Chairman/CEO, Summit Biosciences Inc.)
Lisa N. Drakeman, Ph.D. (CEO, Genmab)
Sander A. Flaum (CEO, Flaum Partners
Adjunct Professor of Management at Fordham Graduate Business School, Founder and Chair of the Fordham Leadership Forum)
Wendy R.Sanhai, Ph.D. (Senior Scientific Advisor, Office of the Commissioner, FDA)
Contact: Ann Rakoff, CorpCtr. or Sandra Sherman, IP Law Institute
Telephone: CorpCtr. (212) 636 - 7985, IP (212) 636 - 7177